GVAX vaccines for PDAC are derived from two pancreatic cancer cell lines engineered with the GM-CSF gene; these vaccines can be injected intradermally and secrete high levels of GM-CSF to attract APCs and promote their maturation. This evidence concerns the gene CSF2 and familial pancreatic carcinoma.